Investor Presentaiton
Department of Health
Notes to the financial statements
For the year ended on 30 June 2023
7.1.2
Restricted cash and cash equivalents
Restricted cash and cash equivalents
Current
Capital work
Commonwealth specific purpose grants (a)
Donation HBF Detect Snapshot
Grants - WA Detect Schools COVID-19 Project
Telethon - WA Child Research Fund Account (c)
The Challenge Prize
WA Future Health Research and Innovation Account (b)
Other
Total current
Non-current
Accrued salaries suspense account (d)
Total non-current
2023
2022
$'000
$'000
7,133
38,453
82,157
964
1,159
2
2
11,681
11,356
2,000
54,575
24,464
241
115,049
119,138
4,481
4,481
4,481
4,481
Total restricted cash and cash equivalents
119,530
123,619
a) Funds held for specific purposes include COVID-19 Response ($12.2 million), NPA - Essential Vaccines ($6.0 million), Health Innovation Fund ($2.1 million), Primary
Care Pilot ($5.8 million) and other initiatives and programs ($11.9 million).
b) Funds received from the State to support future health research and innovation. Refer to note 9.9 'Special purpose accounts'.
c) Funds received from the Channel 7 Telethon Trust, the department and other donors to fund and promote child and adolescent health research in Western Australia.
Refer to note 9.9 'Special purpose accounts'.
d) Funds held in the suspense account for the purpose of meeting the 27th pay in a reporting period that occurs every 11th year. This account is classified as non-current
for 10 out of 11 years.
<
175
Contents
About us
Significant issues Report on operations Agency performance Operational disclosures ⚫Key performance indicators
Financial disclosures and compliance • AppendixView entire presentation